Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1493379rdf:typepubmed:Citationlld:pubmed
pubmed-article:1493379lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0006675lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0006668lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0006669lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0006674lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:1493379lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1493379pubmed:issue4lld:pubmed
pubmed-article:1493379pubmed:dateCreated1993-3-11lld:pubmed
pubmed-article:1493379pubmed:abstractTextWe used the CA-77 cell, a murine C-cell line derived from a medullary thyroid carcinoma, to study the effects of glucocorticoids, calcium, and vitamin D metabolites on calcitonin (CT) gene expression. Total RNA was isolated, and CT and CT gene-related peptide (CGRP) mRNAs were measured by Northern hybridizations using specific probes. A control mRNA probe (cyclophilin) was used to quantitate the specificity of the changes in CT and CGRP mRNAs. The CA-77 C cell line cultured in basal conditions with a medium deprived of fetal calf serum, but was supplemented by insulin, expressed mainly the CGRP mRNA. Dexamethasone was found to increase both CT and CGRP mRNAs in a time- and dose-dependent way without changing the alternative splicing. A slight but significant increase in the steady-state CT mRNA level was found 3 days after addition of 10(-10) M dexamethasone; the same dose slightly decreased the CGRP mRNA level; concentrations of dexamethasone > or = 10(-9) M elevated both mRNAs. A twelve-fold increase for CT mRNA, and an eightfold increase in CGRP mRNA occurred 3 days after administration of 10(-6) M dexamethasone. Kinetic data revealed inductions of both mRNAs 24 hours after exposure to 10(-7) M dexamethasone, and highest CT and CGRP mRNAs levels were observed after 72 hours of treatment. Calcium from 1-4 mM in short-term (1 hour and 4 hour) or long-term stimulations (1 day and 4 days), with or without dexamethasone cotreatment was ineffective. CT and CGRP mRNAs levels were both half-reduced 48 hours after addition of 10(-7) M 1,25-dihydroxycholecalciferol; this effect was transient, as it disappeared 2 days later.lld:pubmed
pubmed-article:1493379pubmed:languageenglld:pubmed
pubmed-article:1493379pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:citationSubsetIMlld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1493379pubmed:statusMEDLINElld:pubmed
pubmed-article:1493379pubmed:issn1050-7256lld:pubmed
pubmed-article:1493379pubmed:authorpubmed-author:GarelJ MJMlld:pubmed
pubmed-article:1493379pubmed:authorpubmed-author:TahriE HEHlld:pubmed
pubmed-article:1493379pubmed:authorpubmed-author:LaborieCClld:pubmed
pubmed-article:1493379pubmed:authorpubmed-author:el M'SelmiAAlld:pubmed
pubmed-article:1493379pubmed:authorpubmed-author:CollignonHHlld:pubmed
pubmed-article:1493379pubmed:issnTypePrintlld:pubmed
pubmed-article:1493379pubmed:volume2lld:pubmed
pubmed-article:1493379pubmed:ownerNLMlld:pubmed
pubmed-article:1493379pubmed:authorsCompleteYlld:pubmed
pubmed-article:1493379pubmed:pagination361-5lld:pubmed
pubmed-article:1493379pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:meshHeadingpubmed-meshheading:1493379-...lld:pubmed
pubmed-article:1493379pubmed:year1992lld:pubmed
pubmed-article:1493379pubmed:articleTitleEffects of dexamethasone, calcium and 1,25-dihydroxycholecalciferol on calcitonin and calcitonin gene-related peptide mRNA levels from the CA-77 C cell line.lld:pubmed
pubmed-article:1493379pubmed:affiliationUniversity of Pierre and Marie Curie, Paris.lld:pubmed
pubmed-article:1493379pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1493379pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed